NCT05333367 MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy
| NCT ID | NCT05333367 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Besancon |
| Condition | Cutaneous T-Cell Lymphoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-04-15 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2022-04-15 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.
Eligibility Criteria
Inclusion Criteria: * Adult patients * Treated with ECP for at least 1 month, for control of GVHD in hematopoietic cell allograft (acute or chronic GVHD), treatment and control of cellular or humoral rejection in solid organ transplantation (heart, lung, kidney) or in the treatment of cutaneous T-cell lymphoma Exclusion Criteria: * Subjects with limited legal capacity. * Subjects judged by the investigator to be unlikely to comply with study procedures * Subjects with no social security coverage. * Pregnant women. * Subjects still in the exclusion period of another study, or according to the national registry of clinical trial participants.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05333367 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Cutaneous T-Cell Lymphoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05333367 currently recruiting?
Yes, NCT05333367 is actively recruiting participants. Contact the research team at cvauchy@chu-besancon.fr for enrollment information.
Where is the NCT05333367 trial being conducted?
This trial is being conducted at Besançon, France.
Who is sponsoring the NCT05333367 clinical trial?
NCT05333367 is sponsored by Centre Hospitalier Universitaire de Besancon. The trial plans to enroll 20 participants.